Corinne Chadéneau Selected Research

Neuropeptides

1/2019	PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP.
3/2015	Neuropeptides of the VIP family inhibit glioblastoma cell invasion.
11/2008	Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
10/2008	Vasoactive intestinal peptide-induced neuritogenesis in neuroblastoma SH-SY5Y cells involves SNAP-25.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Corinne Chadéneau Research Topics

Disease

6	Neoplasms (Cancer) 01/2019 - 11/2008
6	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 04/2010
5	Neuroblastoma 04/2016 - 02/2004
1	Glioma (Gliomas) 11/2014

Drug/Important Bio-Agent (IBA)

5	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2019 - 02/2004
4	NeuropeptidesIBA 01/2019 - 10/2008
4	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 01/2019 - 11/2006
3	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2019 - 10/2008
2	cyclopamineIBA 12/2011 - 04/2010
2	ProdrugsIBA 12/2011 - 04/2010
2	GlucuronidesIBA 12/2011 - 04/2010
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 11/2014
1	Type I Vasoactive Intestinal Polypeptide ReceptorsIBA 11/2014
1	Pharmaceutical PreparationsIBA 12/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2008

Therapy/Procedure

2	Therapeutics 03/2015 - 11/2008
1	Drug Therapy (Chemotherapy) 04/2010